MERCK: Palivizumab (MK 1654)
Clinical Trial Grant
Administered By
Pediatrics, Critical Care Medicine
Awarded By
Merck Sharp & Dohme LLC.
Start Date
October 10, 2022
End Date
December 31, 2024
Administered By
Pediatrics, Critical Care Medicine
Awarded By
Merck Sharp & Dohme LLC.
Start Date
October 10, 2022
End Date
December 31, 2024